Culper Research & ADMA Biologics
2 shared events · Importance 3 · Last updated Jul 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Culper Research acts as an activist short seller against ADMA Biologics, publishing a report in March 2026 that alleged channel stuffing and fictitious revenue growth.
Regulatory
Culper Research: Culper Research is the investigative firm that published a report alleging ADMA Biologics engaged in channel stuffing and had misleading revenue growth, triggering the stock drop and subsequent lawsuits.
ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.
Apr 01, 2026 · 301 articles
Regulatory
Culper Research: Culper Research published a report alleging channel stuffing and undisclosed related party transactions at ADMA, triggering the stock decline and subsequent lawsuits.
ADMA Biologics: ADMA Biologics is the defendant in the securities class action, accused of making false and misleading statements. The lawsuit and allegations have led to a significant drop in its stock price and could result in substantial financial penalties and reputational harm.
Jun 14, 2026 · 294 articles
90
Culper Research published report ADMA BiologicsADMA Biologics Securities...
90
Culper Research published report ADMA BiologicsADMA Biologics Securities...
60
ADMA Biologics issued rebuttal Culper ResearchADMA Biologics Securities...
ERGEN INTELLIGENCE
Explore this relationship live
Track how Culper Research and ADMA Biologics interact across events, view sentiment trends, and discover connected entities.
Open Dashboard